Home / Mesenchymal Stem Cells / Mouse Mesenchymal Stem Cell Functional Identification Kit

Mouse Mesenchymal Stem Cell Functional Identification Kit

Catalog #: SC010
30 Citations Datasheet / COA / SDS
Catalog # Availability Size / Price Qty
SC010
Verification of Multipotency using the Mouse Mesenchymal Stem Cell Functional Identification Kit
1 Image
Product Details
Procedure
Citations (30)
FAQs
Supplemental Products
Reviews
Summary Product Datasheets Data Images Background

Mouse Mesenchymal Stem Cell Functional Identification Kit Summary

Kit Summary

To verify multipotency of mouse mesenchymal stem cells by in vitro functional differentiation.

Key Benefits

  • Confirms that the starting MSC population is multipotent
  • Reduces experimental variation
  • Reliably induces MSC trilineage differentiation using defined supplements
  • Includes premium quality antibodies to confirm differentiation

 

Why Functionally Verify Mouse MSC Multipotency In Vitro?

Mesenchymal stem/stromal cells (MSCs) can be characterized based on the expression of specific cell surface markers, the absence of hematopoietic markers, and adherence to plastic in vitro.

To more rigorously determine if a cell is truly an MSC, it is important to also verify its ability to differentiate into adipocytes, chondrocytes, and osteocytes.

Functional verification of MSC multipotency in vitro:

  • Uses defined supplements to drive reproducible trilineage differentiation.
  • Verifies a healthy, multipotent starting MSC population to increase consistency between studies and reduce unwanted experimental variability.
  • Meets one of the three recommended minimal criteria for MSC identification.
 

 

Mesenchymal Stromal Cells or Mesenchymal Stem Cells?

The term ‘mesenchymal stromal cells’ is commonly used to describe a heterogeneous population of cultured cells that are adherent to plastic, have a distinct morphology, and express a specific set of marker proteins. Within this heterogeneous population are cells referred to as ‘mesenchymal stem cells.’

Mesenchymal stem cells are multipotent, self-renewing cells that have the ability to differentiate into adipocytes, chondrocytes, and osteoblasts when cultured in vitro. Read More about MSC Nomenclature

 

 

Kit Components

This kit contains the following reagents to drive mouse MSC differentiation and a marker to analyze each of the three differentiated derivatives:

  • Adipogenic Supplement
  • Chondrogenic Supplement
  • Osteogenic Supplement
  • ITS Supplement
  • Adipocyte marker: Goat Anti-Mouse FABP4 Antigen-affinity Purified Polyclonal Antibody
  • Chondrocyte marker: Sheep Anti-Mouse Collagen II Antigen-affinity Purified Polyclonal Antibody
  • Osteocyte marker: Goat Anti-Mouse Osteopontin Antigen-affinity Purified Polyclonal Antibody

This kit requires media (not included), such as Human/Mouse/Rat StemXVivo® Osteogenic/Adipogenic Base Media (Catalog #CCM007) or equivalent.

This is enough media for the differentiation of 16 wells of a 24-well plate for osteogenic and adipogenic lineages and 10 chondrocyte pellets.

 

2006 Proposed Change to MSC Nomenclature

Although mesenchymal stromal cells were once referred to as ‘mesenchymal stem cells’, a change to ‘mesenchymal stromal cells’ was proposed by the International Society for Cellular Therapy in 2006.1

The change in nomenclature originates from two important factors:

  • Methods used to isolate mesenchymal stem cells yield a heterogeneous population of cells with only a fraction of these cells demonstrating multipotency.
  • The absence of direct evidence that mesenchymal stem cells can self-renew and differentiate in vivo.

Use of Mesenchymal Stem and Stromal Cell Terminology

Data supporting MSC self-renewal and multipotency have been obtained using in vitro conditions, which does not adequately reflect the in vivo environment. The lack of in vivo data has led some researchers to question the validity of the term ‘mesenchymal stem cell’ providing further support for the use of ‘mesenchymal stromal cells’ to describe MSCs.2 While ‘mesenchymal stromal cells’ may be the more scientifically accurate term for MSCs, the two terms are often used interchangeably in the literature. R&D Systems recognizes the use of both mesenchymal stem cells and mesenchymal stromal cells and uses ‘MSC’ to indicate mesenchymal stem/stromal cells to account for both designations.

Definitions of Mesenchymal Stromal Cells and Mesenchymal Stem Cells

  • Mesenchymal Stromal Cells – A heterogeneous population of cultured cells with similar characteristics such as the ability to adhere to plastic and the expression of specific marker proteins.
  • Mesenchymal Stem Cells – A subpopulation of mesenchymal stromal cells that have the capacity to self-renew and differentiate into mesodermal lineages when cultured in vitro. The capacity to self-renew and differentiate in vivo has yet to be clearly demonstrated for mesenchymal stem cells.

References

  • Dominici, M. et al. (2006) Cytotherapy 8:315.
  • Keating, A. (2012) Cell Stem Cell 10:709.

Specifications

Shipping Conditions
The product is shipped with dry ice or equivalent. Upon receipt, store it immediately at the temperature recommended below.
Storage
Store the unopened product at -20 to -70 °C. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Do not use past expiration date.
Species
Mouse

Product Datasheets

You must select a language.

x
Product Datasheet
COA
SDS

Scientific Data

Immunocytochemistry Verification of Multipotency using the Mouse Mesenchymal Stem Cell Functional Identification Kit View Larger

Verification of Multipotency using the Mouse Mesenchymal Stem Cell Functional Identification Kit Mouse mesenchymal stem cells were cultured in StemXVivo®Mesenchymal Stem Cell Expansion Media (Catalog # CCM004) and differentiation was induced as indicated using the media supplements included in the Mouse Mesenchymal Stem Cell Functional Identification Kit (Catalog # SC010). The kit also contains a Goat Anti-Mouse FABP-4 Antigen Affinity-purified Polyclonal Antibody (adipocytes), a Sheep Anti-Mouse Collagen II Antigen Affinity-purified Polyclonal Antibody (chondrocytes), and a Goat Anti-Mouse Osteopontin Antigen Affinity-purified Polyclonal Antibody (osteocytes) for the confirmation of differentiation status. The cells were stained using the NorthernLights™557-conjugated Donkey Anti-Goat (Catalog # NL001; red) or Anti-Sheep (Catalog # NL010; red) IgG Secondary Antibodies, and the nuclei were counterstained with DAPI (blue).

Assay Procedure

Refer to the product datasheet for complete product details.

Briefly, mouse MSC multipotency is verified using the following in vitro differentiation procedure:

  • Culture multipotent cells of interest
  • Induce adipocyte, chondrocyte, and osteocyte differentiation using media supplements
  • Evaluate differentiation using mature phenotype marker antibodies and fluorescent ICC
SC010 Protocol Graphic Summary
View Graphic Procedure
 

 

Reagents Provided

Reagents supplied in the Mouse Mesenchymal Stem Cell Functional Identification Kit (Catalog # SC010):

  • Adipogenic Supplement
  • Chondrogenic Supplement
  • Osteogenic Supplement
  • ITS Supplement
  • Adipocyte marker: Goat Anti-Mouse FABP4 Antigen-affinity Purified Polyclonal Antibody
  • Chondrocyte marker: Sheep Anti-Mouse Collagen II Antigen-affinity Purified Polyclonal Antibody
  • Osteocyte marker: Goat Anti-Mouse Osteopontin Antigen-affinity Purified Polyclonal Antibody

Note: The quantity of each media supplement in this kit is sufficient to make 50 mL of media for differentiation. 50 mL can be used for 16 wells of a 24-well plate for osteogenic and adipogenic lineages and 10 chondrocyte pellets.

 

Other Supplies Required

Reagents

  • StemXVivo™ Osteogenic/Adipogenic Base Media (Catalog # CCM007 or equivalent)
  • D-MEM/F-12 (1X)
  • Phosphate Buffered Saline (PBS)
  • Penicillin-Streptomycin-Glutamate (100X)
  • 4% Paraformaldehyde in PBS
  • Zinc Formalin
  • 1% BSA in PBS
  • Mounting medium (Catalog # CTS011 or equivalent)
  • NorthernLights™ 557-conjugated Donkey Anti-Goat IgG Secondary Antibody (Catalog # NL001 and NL010 or equivalent)
  • 0.05% Tween® 20 in PBS
  • 0.3% Triton® X-100, 1% BSA, 10% normal donkey serum in PBS
  • 1% BSA, 10% normal donkey serum in PBS
  • Fibronectin (optional; Human Fibronectin, Catalog # 1918-FN, Bovine Fibronectin, Catalog # 1030-FN, or equivalent)
  • Universal Antigen Retrieval Reagent (Catalog # CTS015)
  • Deionized or distilled water

Materials

  • Mouse MSCs
  • 24-well culture plates
  • 12 mm coverslips (Carolina Biologicals, Catalog # 633009 or equivalent)
  • 15 mL centrifuge tubes
  • Pipettes and pipette tips
  • Serological pipettes
  • Glass slides
  • Fine pointed curved forceps
  • Liquid barrier pen

Equipment

  • 37 °C and 5% CO2 incubator
  • Centrifuge
  • Hemocytometer
  • Inverted microscope
  • 2 °C to 8 °C refrigerator
  • 37 °C water bath
  • Fluorescence microscope
  • Cryostat
 

 

Procedure Overview

This protocol has been tested using bone marrow- and/or adipose tissue-derived MSCs. If using a different tissue source or cell line, the protocol below may need to be optimized.

Adipogenic Differentiation

Plate 2.1 x 104 MSCs/cm2 in StemXVivo® Osteogenic/Adipogenic Base Media.

Culture cells to 100% confluency.

Culture cells to 100% confluency.

Replace the medium with Adipogenic Differentiation Medium to induce adipogenesis.

Replace the medium with Adipogenic Differentiation Medium to induce adipogenesis.

Every 3-4 days, replace with fresh Adipogenic Differentiation Medium.

After 10-14 days, adipocytes can be fixed.

 

ICC detection of FABP4.

ICC detection of FABP4.

Osteogenic Differentiation

 

Plate 4.2 x 103 MSCs/cm2 in StemXVivo® Osteogenic/Adipogenic Base Media.

Culture cells to 50-70% confluency.

Plate 4.2 x 103 MSCs/cm 2 in StemXVivo Osteogenic/Adipogenic Base Media.

Replace the medium with Osteogenic Differentiation Media to induce osteogenesis.

Replace the medium with Osteogenic Differentiation Medium to induce osteogenesis.

Every 3-4 days, replace with fresh Osteogenic Differentiation Medium.

After 14-21 days, osteocytes can be fixed.

 

ICC detection of Osteopontin.

ICC detection of Osteocalcin.

Chondrogenic Differentiation

 

Transfer 2.5 x 105 MSCs to a 15 mL conical tube.

Centrifuge and resuspend the cells in Chondrogenic Differentiation Media.

Centrifuge the cells but do not remove the medium.

Transfer 2.5 x 104 MSCs to a 15 mL conical tube.

Every 2-3 days, replace with fresh Chondrogenic Differentiation Media.

After 17-21 days, the chondrogenic pellet can be fixed.

Every 2-3 days, replace with fresh Chondrogenic Differentiation Media.

Cryosection the chondrogenic pellet.

 

ICC detection Collagen II.

ICC detection of Aggrecan.

Citations for Mouse Mesenchymal Stem Cell Functional Identification Kit

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

30 Citations: Showing 1 - 10
Filter your results:

Filter by:

  1. Mesenchymal Stem Cells Genetically Modified by Lentivirus-Express Soluble TRAIL and Interleukin-12 Inhibit Growth and Reduced Metastasis-Relate Changes in Lymphoma Mice Model
    Authors: AG Quiroz-Rey, CA Gonzalez-V, AY Limon-Flor, P Delgado-Go, HG Martinez-R, SL Said-Ferna, A Soto-Domin, AM Rivas-Esti, JF Islas, JF Molina-De, EN Garza-Trev
    Biomedicines, 2023-02-17;11(2):.  2023-02-17
  2. The Effects of Hypoxic Preconditioned Murine Mesenchymal Stem Cells on Post-Infarct Arrhythmias in the Mouse Model
    Authors: B Ahmad, A Skorska, M Wolfien, H Sadraddin, H Lemcke, P Vasudevan, O Wolkenhaue, G Steinhoff, R David, R Gaebel
    International Journal of Molecular Sciences, 2022-08-09;23(16):.  2022-08-09
  3. A combined antitumor strategy of separately transduced mesenchymal stem cells with soluble TRAIL and IFNbeta produces a synergistic activity in the reduction of lymphoma and mice survival enlargement
    Authors: AG Quiroz-Rey, CA González-V, H Martínez-R, S Said-Ferná, MC Salinas-Ca, AY Limón-Flor, A Soto-Domín, G Padilla-Ri, R Montes De, JF Islas, EN Garza-Trev
    Molecular Medicine Reports, 2022-04-29;25(6):.  2022-04-29
  4. Resistance of bone marrow stroma to genotoxic preconditioning is determined by p53
    Authors: N Fedtsova, EA Komarova, KF Greene, LR Novototska, I Molodtsov, CM Brackett, E Strom, AS Gleiberman, AN Shakhov, AV Gudkov
    Cell Death & Disease, 2021-05-26;12(6):545.  2021-05-26
  5. Effects of protein malnutrition on haematopoietic regulatory activity of bone marrow mesenchymal stem cells
    Authors: AA Hastreiter, GG Dos Santos, EN Makiyama, EWC Santos, P Borelli, RA Fock
    The Journal of nutritional biochemistry, 2021-03-08;0(0):108626.  2021-03-08
  6. Myh11+ microvascular mural cells and derived mesenchymal stem cells promote retinal fibrosis
    Authors: HC Ray, BA Corliss, AC Bruce, S Kesting, P Dey, J Mansour, SA Seaman, CM Smolko, C Mathews, BK Dey, GK Owens, SM Peirce, PA Yates
    Sci Rep, 2020-09-25;10(1):15808.  2020-09-25
  7. Cystine transporter expression is a marker to identify a subpopulation of canine adipose-derived stem cells
    Authors: H Itoh, S Nishikawa, K Tani, H Sunahara, M Nakaichi, T Iseri, Y Taura, K Itamoto
    J. Vet. Med. Sci., 2020-04-09;0(0):.  2020-04-09
  8. Adult bone marrow progenitors become decidual cells and contribute to embryo implantation and pregnancy
    Authors: R Tal, S Shaikh, P Pallavi, A Tal, F López-Girá, F Lyu, YY Fang, S Chinchanik, Y Liu, HJ Kliman, M Alderman, N Pluchino, J Kayani, R Mamillapal, DS Krause, HS Taylor
    PLoS Biol., 2019-09-12;17(9):e3000421.  2019-09-12
  9. Potential Role of the Resident Mesenchymal Stem-Like Cells in Renal Fibrogenesis after Ureteral Obstruction
    Authors: YH Peng, J Xiao, C Yan, L Luo, TS Li
    Stem Cells Int, 2019-03-05;2019(0):2543171.  2019-03-05
  10. Increased insulin-like growth factor 1 production by polyploid adipose stem cells promotes growth of breast cancer cells
    Authors: R Fajka-Boja, A Marton, A Tóth, P Blazsó, V Tubak, B Bálint, I Nagy, Z Heged?s, C Vizler, RL Katona
    BMC Cancer, 2018-09-05;18(1):872.  2018-09-05
  11. Targeting Murine Mesenchymal Stem Cells to Kidney Injury Molecule-1 Improves Their Therapeutic Efficacy in Chronic Ischemic Kidney Injury
    Authors: X Zou, K Jiang, AS Puranik, KL Jordan, H Tang, X Zhu, LO Lerman
    Stem Cells Transl Med, 2018-02-15;0(0):.  2018-02-15
  12. Osteogenic Factor Runx2 Marks a Subset of Leptin Receptor-Positive Cells that Sit Atop the Bone Marrow Stromal Cell Hierarchy
    Authors: M Yang, A Arai, N Udagawa, T Hiraga, Z Lijuan, S Ito, T Komori, T Moriishi, K Matsuo, K Shimoda, AH Zahalka, Y Kobayashi, N Takahashi, T Mizoguchi
    Sci Rep, 2017-07-10;7(1):4928.  2017-07-10
  13. Aldehyde dehydrogenase activity identifies a subpopulation of canine adipose-derived stem cells with higher differentiation potential
    Authors: H Itoh, S Nishikawa, T Haraguchi, Y Arikawa, S Etoh, T Iseri, K Tani, M Nakaichi, Y Taura, K Itamoto
    J. Vet. Med. Sci., 2017-06-05;0(0):.  2017-06-05
  14. Synergistic antibacterial effect of co-administering adipose-derived mesenchymal stromal cells and Ophiophagus hannah L-amino acid oxidase in a mouse model of methicillin-resistant Staphylococcus aureus-infected wounds
    Authors: YY Mot, I Othman, SH Sharifah
    Stem Cell Res Ther, 2017-01-23;8(1):5.  2017-01-23
  15. Lnk is an important modulator of insulin-like growth factor-1/Akt/peroxisome proliferator-activated receptor-gamma axis during adipogenesis of mesenchymal stem cells
    Korean J Physiol Pharmacol, 2016-08-26;20(5):459-66.  2016-08-26
  16. MFG-E8 drives melanoma growth by stimulating mesenchymal stromal cell-induced angiogenesis and M2 polarization of tumor-associated macrophages
    Cancer Res, 2016-05-17;0(0):.  2016-05-17
  17. Age-dependent modulation of vascular niches for haematopoietic stem cells
    Authors: AP Kusumbe, SK Ramasamy, T Itkin, MA Mäe, UH Langen, C Betsholtz, T Lapidot, RH Adams
    Nature, 2016-04-13;0(0):.  2016-04-13
  18. Fanconi Anemia Mesenchymal Stromal Cells-Derived Glycerophospholipids Skew Hematopoietic Stem Cell Differentiation Through Toll-Like Receptor Signaling.
    Authors: Amarachintha S, Sertorio M, Wilson A, Li X, Pang Q
    Stem Cells, 2015-07-24;33(11):3382-96.  2015-07-24
  19. Engineered mesenchymal stem cells with enhanced tropism and paracrine secretion of cytokines and growth factors to treat traumatic brain injury.
    Authors: Wang Z, Wang Y, Wang Z, Gutkind J, Wang Z, Wang F, Lu J, Niu G, Teng G, Chen X
    Stem Cells, 2015-02-01;33(2):456-67.  2015-02-01
  20. Skin-derived mesenchymal stem cells help restore function to ovaries in a premature ovarian failure mouse model.
    Authors: Lai D, Wang F, Dong Z, Zhang Q
    PLoS ONE, 2014-05-30;9(5):e98749.  2014-05-30
  21. Mesenchymal stromal (stem) cells suppress pro-inflammatory cytokine production but fail to improve survival in experimental staphylococcal toxic shock syndrome.
    Authors: Kim H, Darwish I, Monroy M, Prockop D, Liles W, Kain K
    BMC Immunol, 2014-01-14;15(0):1.  2014-01-14
  22. Adipose stromal cells contain phenotypically distinct adipogenic progenitors derived from neural crest.
    Authors: Sowa, Yoshihir, Imura, Tetsuya, Numajiri, Toshiaki, Takeda, Kosuke, Mabuchi, Yo, Matsuzaki, Yumi, Nishino, Kenichi
    PLoS ONE, 2013-12-31;8(12):e84206.  2013-12-31
  23. miR-126 and miR-126* repress recruitment of mesenchymal stem cells and inflammatory monocytes to inhibit breast cancer metastasis.
    Authors: Zhang Y, Yang P, Sun T, Li D, Xu X, Rui Y, Li C, Chong M, Ibrahim T, Mercatali L, Amadori D, Lu X, Xie D, Li Q, Wang X
    Nat Cell Biol, 2013-02-10;15(3):284-94.  2013-02-10
  24. Identification of a candidate proteomic signature to discriminate multipotent and non-multipotent stromal cells.
    Authors: Rosu-Myles M, She YM, Fair J
    PLoS ONE, 2012-06-13;7(6):e38954.  2012-06-13
  25. Contribution of stem cells to neointimal formation of decellularized vessel grafts in a novel mouse model.
    Authors: Tsai TN, Kirton JP, Campagnolo P, Zhang L, Xiao Q, Zhang Z, Wang W, Hu Y, Xu Q
    Am. J. Pathol., 2012-05-19;181(1):362-73.  2012-05-19
  26. MiR-1 and miR-200 inhibit EMT via Slug-dependent and tumorigenesis via Slug-independent mechanisms.
    Authors: Liu Y, Yin J, Abou-Kheir W, Hynes P, Casey O, Fang L, Yi M, Stephens R, Seng V, Sheppard-Tillman H, Martin P, Kelly K
    Oncogene, 2012-02-27;32(3):296-306.  2012-02-27
  27. Adipose-derived stem cells produce factors enhancing peripheral nerve regeneration: influence of age and anatomic site of origin.
    Stem Cells Dev., 2012-01-26;21(11):1852-62.  2012-01-26
  28. Quantification of protein isoforms in mesenchymal stem cells by reductive dimethylation of lysines in intact proteins.
    Authors: She Y, Rosu-Myles M, Walrond L, Cyr T
    Proteomics, 2012-01-13;12(3):369-79.  2012-01-13
  29. Age-related changes in rat bone-marrow mesenchymal stem cell plasticity.
    Authors: Asumda FZ, Chase PB
    BMC Cell Biol., 2011-10-12;12(0):44.  2011-10-12
  30. Toll-like receptor 2 mediates mesenchymal stem cell-associated myocardial recovery and VEGF production following acute ischemia-reperfusion injury.
    Authors: Abarbanell AM, Wang Y, Herrmann JL
    Am. J. Physiol. Heart Circ. Physiol., 2010-02-19;298(5):H1529-36.  2010-02-19

FAQs

No product specific FAQs exist for this product, however you may

View all Stem Cell Product FAQs
Loading...

Reviews for Mouse Mesenchymal Stem Cell Functional Identification Kit

There are currently no reviews for this product. Be the first to review Mouse Mesenchymal Stem Cell Functional Identification Kit and earn rewards!

Have you used Mouse Mesenchymal Stem Cell Functional Identification Kit?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review